Loading…

Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity

Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD -dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of virology 2024-03, Vol.98 (3), p.e0008824
Main Authors: Yu, Shuang-Shuang, Tang, Rong-Chun, Zhang, Ao, Geng, Shijin, Yu, Hengxiang, Zhang, Yan, Sun, Xiu-Yuan, Zhang, Jun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3
container_end_page
container_issue 3
container_start_page e0008824
container_title Journal of virology
container_volume 98
creator Yu, Shuang-Shuang
Tang, Rong-Chun
Zhang, Ao
Geng, Shijin
Yu, Hengxiang
Zhang, Yan
Sun, Xiu-Yuan
Zhang, Jun
description Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD -dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705). primary peritoneal macrophages and mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.
doi_str_mv 10.1128/jvi.00088-24
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10949466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2968924005</sourcerecordid><originalsourceid>FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3</originalsourceid><addsrcrecordid>eNp1kctP3DAQxi1EBcvjxrnyEaQG_LZzQghKuxIqB0DiZs06ztarxFliZ6X97xvYBcGhp9HM_PTN40PohJJzSpm5WKzCOSHEmIKJHTShpDSFlFTsogkhjBWSm-d9dJDSghAqhBJ7aJ8bbpQ2dIKqGw_O53UDyeOH0OchRExxG3KYQ_YJ5_XS4yme3v4pMMRqm28KIVaD8xVOYR6hCXH-RkDMYRV6aHBo2yGGvD5C32pokj_exkP0dPvz8fp3cXf_a3p9dVcA5yYXToJjzjiuda31DBxI5YmUQknlCFFG69I4qsVYEZ5BSStdz2oualMZV9f8EF1udJfDrPWV8zGPa9hlH1ro17aDYL92Yvhr593Kjk8TpVBqVDjdKvTdy-BTtm1IzjcNRN8NybJSmZIJQuSI_tigru9S6n39MYcS--qMHZ2xb85YJkb8bINDaplddEM_viz9j_3--Y4P4Xfb-D87upeS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2968924005</pqid></control><display><type>article</type><title>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</title><source>Open Access: PubMed Central</source><source>American Society for Microbiology Journals</source><creator>Yu, Shuang-Shuang ; Tang, Rong-Chun ; Zhang, Ao ; Geng, Shijin ; Yu, Hengxiang ; Zhang, Yan ; Sun, Xiu-Yuan ; Zhang, Jun</creator><contributor>Ou, J.-H. James</contributor><creatorcontrib>Yu, Shuang-Shuang ; Tang, Rong-Chun ; Zhang, Ao ; Geng, Shijin ; Yu, Hengxiang ; Zhang, Yan ; Sun, Xiu-Yuan ; Zhang, Jun ; Ou, J.-H. James</creatorcontrib><description>Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD -dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705). primary peritoneal macrophages and mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.</description><identifier>ISSN: 0022-538X</identifier><identifier>ISSN: 1098-5514</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/jvi.00088-24</identifier><identifier>PMID: 38386781</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Immunity, Innate ; Immunology ; Interferon Type I - metabolism ; Interferon-gamma ; Mice ; Phosphorylation ; Signal Transduction ; Sirtuin 1 - genetics ; Sirtuin 1 - metabolism ; STAT1 Transcription Factor - metabolism ; Virus Diseases - immunology ; Virus-Cell Interactions</subject><ispartof>Journal of virology, 2024-03, Vol.98 (3), p.e0008824</ispartof><rights>Copyright © 2024 American Society for Microbiology.</rights><rights>Copyright © 2024 American Society for Microbiology. 2024 American Society for Microbiology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3</cites><orcidid>0000-0001-5147-6963 ; 0009-0006-8482-8738</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/jvi.00088-24$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/jvi.00088-24$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,27923,27924,52750,52751,52752,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38386781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ou, J.-H. James</contributor><creatorcontrib>Yu, Shuang-Shuang</creatorcontrib><creatorcontrib>Tang, Rong-Chun</creatorcontrib><creatorcontrib>Zhang, Ao</creatorcontrib><creatorcontrib>Geng, Shijin</creatorcontrib><creatorcontrib>Yu, Hengxiang</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Sun, Xiu-Yuan</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><title>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</title><title>Journal of virology</title><addtitle>J Virol</addtitle><addtitle>J Virol</addtitle><description>Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD -dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705). primary peritoneal macrophages and mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.</description><subject>Animals</subject><subject>Immunity, Innate</subject><subject>Immunology</subject><subject>Interferon Type I - metabolism</subject><subject>Interferon-gamma</subject><subject>Mice</subject><subject>Phosphorylation</subject><subject>Signal Transduction</subject><subject>Sirtuin 1 - genetics</subject><subject>Sirtuin 1 - metabolism</subject><subject>STAT1 Transcription Factor - metabolism</subject><subject>Virus Diseases - immunology</subject><subject>Virus-Cell Interactions</subject><issn>0022-538X</issn><issn>1098-5514</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kctP3DAQxi1EBcvjxrnyEaQG_LZzQghKuxIqB0DiZs06ztarxFliZ6X97xvYBcGhp9HM_PTN40PohJJzSpm5WKzCOSHEmIKJHTShpDSFlFTsogkhjBWSm-d9dJDSghAqhBJ7aJ8bbpQ2dIKqGw_O53UDyeOH0OchRExxG3KYQ_YJ5_XS4yme3v4pMMRqm28KIVaD8xVOYR6hCXH-RkDMYRV6aHBo2yGGvD5C32pokj_exkP0dPvz8fp3cXf_a3p9dVcA5yYXToJjzjiuda31DBxI5YmUQknlCFFG69I4qsVYEZ5BSStdz2oualMZV9f8EF1udJfDrPWV8zGPa9hlH1ro17aDYL92Yvhr593Kjk8TpVBqVDjdKvTdy-BTtm1IzjcNRN8NybJSmZIJQuSI_tigru9S6n39MYcS--qMHZ2xb85YJkb8bINDaplddEM_viz9j_3--Y4P4Xfb-D87upeS</recordid><startdate>20240319</startdate><enddate>20240319</enddate><creator>Yu, Shuang-Shuang</creator><creator>Tang, Rong-Chun</creator><creator>Zhang, Ao</creator><creator>Geng, Shijin</creator><creator>Yu, Hengxiang</creator><creator>Zhang, Yan</creator><creator>Sun, Xiu-Yuan</creator><creator>Zhang, Jun</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5147-6963</orcidid><orcidid>https://orcid.org/0009-0006-8482-8738</orcidid></search><sort><creationdate>20240319</creationdate><title>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</title><author>Yu, Shuang-Shuang ; Tang, Rong-Chun ; Zhang, Ao ; Geng, Shijin ; Yu, Hengxiang ; Zhang, Yan ; Sun, Xiu-Yuan ; Zhang, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Immunity, Innate</topic><topic>Immunology</topic><topic>Interferon Type I - metabolism</topic><topic>Interferon-gamma</topic><topic>Mice</topic><topic>Phosphorylation</topic><topic>Signal Transduction</topic><topic>Sirtuin 1 - genetics</topic><topic>Sirtuin 1 - metabolism</topic><topic>STAT1 Transcription Factor - metabolism</topic><topic>Virus Diseases - immunology</topic><topic>Virus-Cell Interactions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Shuang-Shuang</creatorcontrib><creatorcontrib>Tang, Rong-Chun</creatorcontrib><creatorcontrib>Zhang, Ao</creatorcontrib><creatorcontrib>Geng, Shijin</creatorcontrib><creatorcontrib>Yu, Hengxiang</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Sun, Xiu-Yuan</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Shuang-Shuang</au><au>Tang, Rong-Chun</au><au>Zhang, Ao</au><au>Geng, Shijin</au><au>Yu, Hengxiang</au><au>Zhang, Yan</au><au>Sun, Xiu-Yuan</au><au>Zhang, Jun</au><au>Ou, J.-H. James</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</atitle><jtitle>Journal of virology</jtitle><stitle>J Virol</stitle><addtitle>J Virol</addtitle><date>2024-03-19</date><risdate>2024</risdate><volume>98</volume><issue>3</issue><spage>e0008824</spage><pages>e0008824-</pages><issn>0022-538X</issn><issn>1098-5514</issn><eissn>1098-5514</eissn><abstract>Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD -dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705). primary peritoneal macrophages and mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>38386781</pmid><doi>10.1128/jvi.00088-24</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0001-5147-6963</orcidid><orcidid>https://orcid.org/0009-0006-8482-8738</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2024-03, Vol.98 (3), p.e0008824
issn 0022-538X
1098-5514
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10949466
source Open Access: PubMed Central; American Society for Microbiology Journals
subjects Animals
Immunity, Innate
Immunology
Interferon Type I - metabolism
Interferon-gamma
Mice
Phosphorylation
Signal Transduction
Sirtuin 1 - genetics
Sirtuin 1 - metabolism
STAT1 Transcription Factor - metabolism
Virus Diseases - immunology
Virus-Cell Interactions
title Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A34%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deacetylase%20Sirtuin%201%20mitigates%20type%20I%20IFN-%20and%20type%20II%20IFN-induced%20signaling%20and%20antiviral%20immunity&rft.jtitle=Journal%20of%20virology&rft.au=Yu,%20Shuang-Shuang&rft.date=2024-03-19&rft.volume=98&rft.issue=3&rft.spage=e0008824&rft.pages=e0008824-&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/jvi.00088-24&rft_dat=%3Cproquest_pubme%3E2968924005%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2968924005&rft_id=info:pmid/38386781&rfr_iscdi=true